[1]
Shahid Ullah, “STRUCTURE-BASED VIRTUAL SCREENING STUDY OF FDA‑APPROVED DRUGS TO INHIBIT TP53 72 ARG/PRO VARIANT IDENTIFIED IN ACUTE LYMPHOCYTIC PATIENT VIA WHOLE EXOME SEQUENCING”, J Popl Ther Clin Pharmacol, vol. 31, no. 3, pp. 2304–2415, Mar. 2024, doi: 10.53555/jptcp.v31i3.5046.